Tumor response assessments with diffusion and perfusion MRI.
about
New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal CancerMonitoring early response to anti-angiogenic therapy: diffusion-weighted magnetic resonance imaging and volume measurements in colon carcinoma xenograftsImaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in developmentDCE-MRI and IVIM-MRI of rabbit Vx2 tumors treated with MR-HIFU-induced mild hyperthermia.Whole body MRI: improved lesion detection and characterization with diffusion weighted techniquesPractical estimate of gradient nonlinearity for implementation of apparent diffusion coefficient bias correction.Influence of B1-Inhomogeneity on Pharmacokinetic Modeling of Dynamic Contrast-Enhanced MRI: A Simulation StudyDCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibilityMagnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts.Dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging noninvasive evaluation of vascular disrupting treatment on rabbit liver tumors.DW-MRI in assessment of the hypoxic fraction, interstitial fluid pressure, and metastatic propensity of melanoma xenografts.Body diffusion kurtosis imaging: Basic principles, applications, and considerations for clinical practice.Early Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.Early effects of low dose bevacizumab treatment assessed by magnetic resonance imaging.DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.Perfusion MRI in hips with metal-on-metal and metal-on-polyethylene total hip arthroplasty: A pilot study.Diffusion weighted imaging for the differential diagnosis of benign vs. malignant ovarian neoplasmsThe value of intravoxel incoherent motion model-based diffusion-weighted imaging for outcome prediction in resin-based radioembolization of breast cancer liver metastases.Evaluation of a Simplified Intravoxel Incoherent Motion (IVIM) Analysis of Diffusion-Weighted Imaging for Prediction of Tumor Size Changes and Imaging Response in Breast Cancer Liver Metastases Undergoing Radioembolization: A Retrospective Single CeAnalysis and correction of gradient nonlinearity bias in apparent diffusion coefficient measurements.DCE-MRI Perfusion and Permeability Parameters as predictors of tumor response to CCRT in Patients with locally advanced NSCLC.Intravoxel incoherent motion model-based analysis of diffusion-weighted magnetic resonance imaging with 3 b-values for response assessment in locoregional therapy of hepatocellular carcinoma.Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma.Early detection of antiangiogenic treatment responses in a mouse xenograft tumor model using quantitative perfusion MRI.Feasibility of assessing pulmonary blood volume using C-arm CT during transpulmonary chemoperfusion and chemoembolization in primary and secondary lung tumours.Antiangiogenic therapy for refractory colorectal cancer: current options and future strategies.Whole-body MRI in pediatric patients with cancerCirculating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy.Clinical imaging of tumor angiogenesis.The role of functional imaging in the era of targeted therapy of renal cell carcinoma.MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer.Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicinesFunctional MRI and CT biomarkers in oncology.Whole-body magnetic resonance imaging in children: state of the art.MRI methods for the evaluation of high intensity focused ultrasound tumor treatment: Current status and future needs.Dynamic contrast-enhanced MRI for oncology drug development.In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer.
P2860
Q26786311-9FBA0259-6CFD-4C93-A740-EDD0B6C1D327Q27348906-5CC0AFC1-1F7A-448F-93C7-341E84E029BDQ28083433-76EB2A21-3E8A-4CAA-98FA-F8DED940D61EQ30388286-8F310899-DB72-4FE0-A986-1EF59DC6E8CAQ30662431-D94F42E5-5E83-4726-9A6E-9BC0FF9DFA2DQ30890815-9A31F3E4-EC1F-4725-95C8-96CDBDCBB47BQ33736299-BFDEE3DC-2F4E-4BE0-8F99-29C14A8B233EQ33759248-D50878BE-FE80-41FE-9F99-2C1CB5090C63Q34249349-3FF98E9E-4DC9-49C1-8FA5-2BB27D447256Q35077659-E26BD539-4BDA-46A8-9602-85592F1F6CFBQ35094559-171B2F1E-1AAD-49E6-8860-63E972242A7EQ35676598-7A9EB93C-FC61-4FF0-8173-FC2AA48A9192Q35840971-8E7AD634-7AAC-44AC-A0A0-6989E069F2F9Q35843084-625F1E6B-428B-4C6D-8FC4-1112A5D50D73Q35866622-98CF77E7-13C6-4B07-9B48-4215360B4CBBQ35925442-44D20362-B035-4D83-88E7-D833315DC350Q36089055-7D2299BB-2F3A-47A4-B968-107292D24E55Q36857051-00506944-7CCD-4104-B3B9-ABC3D9591D05Q36954221-5292E3DF-F54F-4067-BECC-BBBBF8DBAA74Q37082835-2F6AF767-E8A0-4517-B561-BD9F0D78DFC6Q37206772-C4736823-2492-4D98-9483-38B46900DECAQ37296871-00A9047D-8BE7-4843-9FFF-5E3BCAA7C7DFQ37352786-585447FB-1F5D-4B81-A1BA-8060D195E519Q37365518-3ABC2196-9499-4EAA-BCA2-439389426A53Q37426851-11041ECD-4BFB-4757-9CD9-E75A6AE554D9Q37595237-D0722C13-B211-49D8-A1CD-66431AB9BE9DQ37601047-EB88C539-C1B7-4C1C-A47F-811E13ECFCE0Q37632167-8F512C35-4F0C-430B-9EF2-DC592AD73592Q37637025-1034DF64-B525-4722-8A18-A6CA463CB486Q38012465-C2C981D7-19B2-457C-A3F6-727983309D66Q38059503-9C38516A-E126-491F-B7D9-BB51FA9BC129Q38099238-8566B5D9-F659-4359-85F8-67688394AC15Q38198858-A3FA9FA5-D6F3-4EC5-BC5C-61A1E77C023EQ38230869-40FE404B-0642-4B27-9527-983169194A17Q38314429-335A4F05-11D3-4EC2-9463-7C7CE9D61B03Q38490512-BB2001D0-C363-4CD4-A201-DA64E4283BDFQ38533886-B26ACB0C-2659-49AF-A558-E89B354BB688Q38725827-A704F547-9B87-498D-B5FD-0F5BB45FF0DAQ38902139-122A50AA-BC89-41C3-B35E-95B56F31FA81Q39068294-FDE4A9D1-6EB5-4620-B904-3D8039E31722
P2860
Tumor response assessments with diffusion and perfusion MRI.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tumor response assessments with diffusion and perfusion MRI.
@en
Tumor response assessments with diffusion and perfusion MRI.
@nl
type
label
Tumor response assessments with diffusion and perfusion MRI.
@en
Tumor response assessments with diffusion and perfusion MRI.
@nl
prefLabel
Tumor response assessments with diffusion and perfusion MRI.
@en
Tumor response assessments with diffusion and perfusion MRI.
@nl
P2860
P356
P1476
Tumor response assessments with diffusion and perfusion MRI.
@en
P2093
Anwar R Padhani
Sonia P Li
P2860
P304
P356
10.1002/JMRI.22838
P577
2012-04-01T00:00:00Z